-
Lupin’s alliance partner Concord gets USFDA nod for Tacrolimus Capsules
expresspharma
November 13, 2020
They are indicated for prophylaxis of organ rejection in adult and paediatric patients receiving allogeneic liver, kidney or heart transplants.
-
Lupin’s Somerset facility gets 13 observations post US FDA inspection
expresspharma
November 10, 2020
The company does not believe that this will have an impact on disruption of supplies or the existing revenues from operations of this facility.
-
Lupin gets US FDA approval for dimethyl fumarate delayed release capsules
expresspharma
October 12, 2020
It is indicated for the treatment of patients with relapsing forms of multiple sclerosis.
-
Lupin launches Fosaprepitant for injection
expresspharma
October 10, 2020
The injection is indicated for acute and delayed nausea and vomiting associated with cancer chemotherapy.
-
Lupin launches atorvastatin calcium tablets
expresspharma
September 30, 2020
It is indicated to lower cholesterol in blood for adults and children over 10 years of age.
-
Lupin launches divalproex sodium ER tablets
expresspharma
September 23, 2020
The product will be manufactured at Lupin’s Nagpur facility in India.
-
Lupin launches Leflunomide Tablets USP
expresspharma
September 03, 2020
These tablets are indicated for the treatment of adults with active rheumatoid arthritis.
-
Lupin and Mylan launch Nepexto, biosimilar etanercept in German market
expresspharma
August 27, 2020
Etanercept was first approved for the treatment of rheumatoid arthritis in Germany in 2000 and since then has offered an effective treatment option for several chronic inflammatory diseases.
-
Lupin gets US FDA approval for generic Albuterol Sulphate MDI
expresspharma
August 26, 2020
It is indicated for the treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.
-
ForDoz, Lupin Enter Injectables Partnership
contractpharma
August 25, 2020
Deal is for two complex injectable products in advanced development stage at ForDoz.